TCA
CANO

Transcend Capital Advisors’s Cano Health, Inc. CANO Stock Holding History

Transcend Capital Advisors’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,631
Closed -$143K – 540
2023
Q3 		$143K Sell
5,631
-27,897
-83% -$2.29M 0.01% 463
2023
Q2 		$4.66M Buy
33,528
+7,174
+27% +$921K 0.44% 49
2023
Q1 		$2.4M Buy
26,354
+7,069
+37% +$960K 0.25% 105
2022
Q4 		$2.64M Buy
19,285
+12,000
+165% +$4.06M 0.29% 86
2022
Q3 		$6.32M Buy
7,285
+960
+15% +$602K 0.7% 28
2022
Q2 		$2.77M Buy
6,325
+2,319
+58% +$1.21M 0.29% 90
2022
Q1 		$2.54M Buy
+4,006
New +$2.53M 0.23% 115

Other funds holding CANO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Transcend Capital Advisors's CANO Position: Q4 2023 in Review

Transcend Capital Advisors sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 5,631 shares — an estimated $143K sold.

Transcend Capital Advisors first reported a position in CANO in Q1 2022 and held it in 7 quarters. The position peaked at $6.32M in Q3 2022. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • Transcend Capital Advisors reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • Transcend Capital Advisors sold 5,631 Cano Health, Inc. shares in Q4 2023, an estimated $143K.
  • Transcend Capital Advisors first reported a position in Cano Health, Inc. in Q1 2022 and held it in 7 quarters.
  • Transcend Capital Advisors's Cano Health, Inc. position peaked at $6.32M in Q3 2022.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Transcend Capital Advisors's 13F filing for Q4 2023, filed 5 Feb 2024.